Dr. Gary Gilliland, a physician-scientist, is an expert in cancer genetics and precision medicine holds a Ph.D. in microbiology and a medical doctorate and was professor of medicine at Harvard Medical School and professor of stem cell and regenerative biology at Harvard University.
Dr. David Maloney, an immunotherapy researcher and physician, has played an instrumental role in the two of the biggest breakthroughs in cancer therapy: the development and testing of Rituximab -- the first targeted antibody-based therapy for cancer -- and today's emerging T-cell therapies.
The National Press Club located on the 13th Floor of the National Press Building, 529 14th Street NW, Washington, D.C. This event is open to credentialed media and NPC members, free of charge. No advance registration is required.
Contact: Jamie Horwitz, Newsmaker Chair at 202/549-4921, email@example.com
Logo - http://photos.prnewswire.com/prnh/20080917/NPCLOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/is-immunotherapy-the-cure-for-cancer-300348589.html
SOURCE National Press Club